「浸潤性膵管癌におけるCD109の造腫瘍性に関する研究」の関連論文
-
Generation and characterization of a novel mouse model that allows spatiotemporal quantification of pancreatic β-cell proliferation
-
Ppp6c遺伝子はマウス舌癌において、がん原性のRASの存在下では、がん抑制遺伝子として働く
-
A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis
-
疾患特異的ヒトiPS細胞を用いた新規ADPKD病態モデルの作製
-
Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance
-
Matrix remodeling-associated protein 8 is a marker of a subset of cancer-associated fibroblasts in pancreatic cancer
-
消化器神経内分泌がんの細胞株を使用した前臨床モデルとPARP阻害剤、EZH2阻害剤の有用性に関する検討
-
The CD44/COL17A1 pathway promotes the formation of multilayered, transformed epithelia
-
癌幹細胞マーカーが、食道扁平上皮癌における術前化学療法の抵抗性を予測する
-
Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model
-
Newly established patient-derived organoid model of intracranial meningioma
-
Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in MYCN-amplified neuroblastoma cells
-
Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma
-
膵癌特異的なrBC2LCNレクチンのリガンドの同定
-
胆管内乳頭状腫瘍(IPNB)は臨床病理学的徴候および分子異常と関連した2つのTypeに分けられる
-
骨肉腫と免疫細胞の相互作用の解明による骨肉腫に対する新規治療標的の探索
-
Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies
-
肝細胞癌に対するレンバニチブ療法の臨床効果に及ぼすNOS3遺伝子多型の影響
-
OX40シグナルおよびCD8陽性T細胞を介するIL-33-ILC2系の抗腫瘍機能の解明
-
Downregulated ATP6V1B1 expression acidifies the intracellular environment of cancer cells leading to resistance to antibody-dependent cellular cytotoxicity
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
-
がんの増殖および転移における乳酸受容体GPR81の役割
-
Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression
-
Extracellular vesicles of stem cells to prevent BRONJ
-
口腔扁平上皮癌におけるprotease-activated receptor 1の発現と機能に関する研究 : ΔNp63を介した上皮間葉転換との関連
-
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
-
肺腺癌におけるOvarian cancer immuno-reactive antigen domain containing 2 (OCIAD2) 発現の臨床病理学的意義および機能解析
-
Glyoxalase Iの欠損とカルボニルストレスの外的な負荷はヒトiPS細胞とヒトiPS細胞由来神経細胞でミトコンドリア機能障害を起こす
-
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma
-
Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production
-
膵癌細胞株におけるゲムシタビン抵抗性獲得メカニズムの探索
-
Trefoil factor family 2 inhibits cholangiocarcinogenesis by regulating the PTEN pathway in mice
-
乳管上皮細胞の癌化のマーカーとしての5hmcの解析
-
Helicobacter pylori除菌後の胃癌発育進展過程に、口腔内雑菌成分刺激によるToll-like receptor 2を介した粘膜バリア傷害が関与する
-
Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity
-
Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells
-
がん治療用ウイルスの胆道癌治療への応用と新規機能付加型HSV-1の開発
-
抗癌剤耐性ABCトランスポーターに対する新規抑制剤の同定と抗癌剤感受性への影響
-
Photosensitizer verteporfin inhibits the growth of YAP‑ and TAZ‑dominant gastric cancer cells by suppressing the anti‑apoptotic protein Survivin in a light‑independent manner
-
Human chromosome 3p21.3 carries TERT transcriptional regulators in pancreatic cancer
-
表皮角化細胞の破砕物による真皮細胞の2型炎症誘導~Itch-scratch cycleによるアトピー性皮膚炎悪化に寄与する分子メカニズムの検討~
-
Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9
-
Clinicopathological and molecular characteristics of endometrial neuroendocrine carcinomas reveal preexisting endometrial carcinoma origin
-
OX40の関節炎自己抗体シアル化の制御における潜在的意義
-
内分泌療法耐性乳癌におけるL型アミノ酸トランスポーター1 (LAT1)を介した代謝変化を標的とした治療戦略の確立
-
胃癌発育進展における歯周病菌Porphyromonas gingivalis リポ多糖の関与
-
Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
-
ランゲルハンス組織球症に対する治療標的候補分子SIRPα
-
マウス扁平上皮癌顎骨浸潤モデルにおける Interleukin-12 発現型第三世代がん治療用 HSV-1 投与効果の検討
-
Elucidation of the factors regulating high invasiveness of pancreatic cancer and the profound involvement of Interleukin 32 in the invasive mechanisms of the tumor cells